TBPH (STOCKS)
Theravance Biopharma, Inc.
$16.500000
+0.150000 (+0.92%)
Prev close: $16.350000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Rick E. Winningham
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $849.12M
- Employees
- 97
- P/E (TTM)
- 7.95
- P/B (TTM)
- 2.81
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $107.46M |
| Benefits Costs and Expenses | -$21.78M |
| Costs And Expenses | -$21.78M |
| Operating Expenses | $111.07M |
| Selling, General, and Administrative Expenses | $73.65M |
| Research and Development | $37.41M |
| Operating Income/Loss | -$3.60M |
| Income/Loss From Continuing Operations After Tax | $105.90M |
| Income/Loss From Continuing Operations Before Tax | $129.25M |
| Income Tax Expense/Benefit | $23.35M |
| Income Tax Expense/Benefit, Current | $34.87M |
| Income Tax Expense/Benefit, Deferred | -$11.52M |
| Net Income/Loss | $105.90M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | $105.90M |
| Net Income/Loss Available To Common Stockholders, Basic | $105.90M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | $2.10 |
| Diluted Earnings Per Share | $2.06 |
| Basic Average Shares | 50,317,000 |
| Diluted Average Shares | 51,507,000 |
| Assets | $485.57M |
| Current Assets | $418.46M |
| Noncurrent Assets | $67.11M |
| Fixed Assets | $5.90M |
| Other Non-current Assets | $61.22M |
| Liabilities | $188.85M |
| Current Liabilities | $38.30M |
| Accounts Payable | $2.57M |
| Wages | $12.59M |
| Other Current Liabilities | $23.14M |
| Noncurrent Liabilities | $150.55M |
| Equity | $296.72M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $296.72M |
| Liabilities And Equity | $485.57M |
| Net Cash Flow From Operating Activities | $238.54M |
| Net Cash Flow From Operating Activities, Continuing | $238.54M |
| Net Cash Flow From Investing Activities | -$105.28M |
| Net Cash Flow From Investing Activities, Continuing | -$105.28M |
| Net Cash Flow From Financing Activities | -$3.25M |
| Net Cash Flow From Financing Activities, Continuing | -$3.25M |
| Net Cash Flow | $130.01M |
| Net Cash Flow, Continuing | $130.01M |
| Comprehensive Income/Loss | $105.95M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | $105.95M |
| Other Comprehensive Income/Loss | $54.00K |